Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized double-blind phase III trial of ZX-7101A dry suspension in 2–11-year-old children with uncomplicated influenza
CTR20252688Phase 3Completed
- Sponsor
- Zenshine Pharmaceuticals Co., Ltd.
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Seloxavir marboxil in influenza, sponsored by Zenshine Pharmaceuticals Co., Ltd.. Started Jul 2025; status: completed.
02
Drugs
Seloxavir marboxil
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20252688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252688.